3 No-Brainer Stocks to Buy in June
Sell in May and go away? The old adage hasn't proven to be great advice in 2023. The stock market has risen so far in June and could go even higher.
Three Motley Fool contributors think some stocks are no-brainers to buy this month. Here's why they especially like Axsome Therapeutics (NASDAQ: AXSM), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX).
Prosper Junior Bakiny (Axsome Therapeutics): Sporting a market cap of just $3.3 billion, Axsome Therapeutics is a relatively small and unknown drugmaker. But it would be unwise to ignore this biotech just because of its size. In fact, the market has yet to factor Axsome Therapeutics' full potential into its share price, which makes the stock a no-brainer buy right now.
Source Fool.com
Axsome Therapeutics Inc Aktie
75,96 €
-3,75 %
Die Community ist noch unentschlossen über Axsome Therapeutics Inc mit wenigen Einschätzungen.
Das Kursziel von 100 € für Axsome Therapeutics Inc bedeutet eine deutliche Steigerung von über 20% gegenüber dem aktuellen Kurs von 75.96 €.
